📄 Direct examination of Dr. Fredric Rieders (morning, part 2) — Monday, July 24, 1995
Address:
C:\DEPT103\CRIMINAL\1995\JUL\24\DIRECT-EXAMINATION-OF-DR-FREDR.DOC
TRIAL
▲ Day 120 of 167

Direct examination of Dr. Fredric Rieders (morning, part 2)

Witness: Dr. Fredric Rieders
Examiner: Robert Blasier
Called by: Defense • Date: Monday, July 24, 1995 • Utterances: 305
Defense attorney Robert Blasier conducted a highly technical direct examination of forensic toxicologist Dr. Fredric Rieders, who testified that FBI mass spectrometry chromatograms of both the sock stain (Q206) and back gate stain (Q204) demonstrated the presence of EDTA — a preservative found in purple-top blood collection tubes — in the evidence blood. Dr. Rieders also systematically criticized the FBI's testing methodology, noting the absence of an internal standard, inadequate extraction procedures for old stains, and a complete lack of validation studies, while opining that the method could not reliably quantify EDTA concentrations.
1 MR. BLASIER:

Thank you, your Honor.

2 MR. BLASIER:

Dr. Rieders, what is a chromatogram?

3 DR. RIEDERS:

A chromatogram is a depiction of what at various times is seen by a detector looking at the end of the column where in this case the liquid comes out and where the liquid itself does not elicit a signal from the detector, but anything that comes out that is not moving liquid, that is not the air stream, that is one of the people, anything that is one of the people walking down the road a mile, comes out, it detects or shows its presence and some measure of how much of it, how many molecules or how high--how large an amount, not concentration, but how large an amount is passing in front of the detector. And depicts that by a peak along the line and every time something comes out there is another peak, if it is seen by the detector.

4 MR. BLASIER:

Your Honor, could I have marked as a group exhibit 2 diagrams, two chromatograms?

5 THE COURT:

1259.

6 MR. BLASIER:

1259-A and B.

7 (Deft's 1259-A and 1259-B for id = slide)
8 MR. BLASIER:

For the record, 1259-A has D.A. discovery no. 4088 and is a chromatogram on sample Q206. 1259-B is D.A. discovery no. 4094 and is also a chromatogram of Q206.

9 THE COURT:

All right. Q206. Thank you.

10 MR. BLASIER:

Doctor, let me show you 1259-A and B. Can you tell me if those are chromatograms?

11 DR. RIEDERS:

Yes.

12 MR. BLASIER:

Now, I would like to--we scanned those and could we have 4088.

13 DR. RIEDERS:

Sir?

14 MR. BLASIER:

We are going to show you something on the monitor, doctor. Doctor, could you look at the monitor and compare what is up there with 4088 that you have in your hand, and other than one being a positive and one being a negative do they appear to be the same?

15 DR. RIEDERS:

Looks like--looks like it is. What is on the monitor is from that same chromatogram.

16 MR. BLASIER:

Now, that is a chromatogram produced by the FBI on the sock stain, correct, the Q206?

17 DR. RIEDERS:

That is correct.

18 MR. BLASIER:

Now, I want to ask you about just a couple of things on this form. I'm going to zoom in a little bit up in this corner, try to here anyway. What does the 160 up in that corner there where the arrow is indicate?

19 DR. RIEDERS:

160? Where is that? In the upper right corner?

20 MR. BLASIER:

The upper left.

21 DR. RIEDERS:

Upper left, I'm sorry. Okay. I see, on the chromatogram itself. It means that what is being monitored by the detecting device is the daughter ion, 160 that has been isolated in the second mass spectrometer and filtered and now filtered and isolated from the other ions and is now impacting on the detector as the liquid is flowing out of the column being transformed into the electrospray, entering the first mass spectrometer and going into the next one where it is converted into a daughter ion so that means that is the ion that is being monitored.

22 MR. BLASIER:

Now, what does that tell you about whether the parent ion--what does that tell you about the 293 parent ion?

23 DR. RIEDERS:

Well, that in and of itself only tells me that one of the daughter ions of whatever it was, that went into the second mass spectrometer and which was the 293 daughter ion, broke up and gave off one piece that is a 160.

24 MR. BLASIER:

So we know that this had to have come from the 293 parent ion?

25 DR. RIEDERS:

Yes.

26 MR. BLASIER:

Now, let me go up a little bit where this peak in the chart is. Can you tell me what the number 37 means?

27 DR. RIEDERS:

The no. 37 is the--you see a line on the bottom. What it does, it counts the number of--the scans that go on. This is scan no. 37 that the detector scans the gas as it comes past, and on the 37th pass it has this particular peak.

28 MR. BLASIER:

Now, is that--

29 DR. RIEDERS:

So that is the retention time of the substance, in terms of number of scans, rather than minutes, but it is the same thing. It is along a movement axis. The liquid flows past and the earliest things are on the right and the current, the latest things, are on the left.

30 MR. BLASIER:

Now, the other two numbers right below the 37, what do those mean?

31 DR. RIEDERS:

The first of these is the detector took in the signals that it got and it added them all up and it measured how big--how high a peak was generated from it in counting units, and the height of that peak was 24 through 223 counting units. The next line, what it does, it makes measurements of all the points in that peak that it can and gives you an area of that peak, because as you can see, that peak has a height and it has an area. You can see it right on there. And the area is 98,443 counts. In short, the area in counts is four times--takes four times--roughly four times as many counts to cover the area than to cover the height.

32 MR. BLASIER:

Now, does the size of the peak--let me withdraw that. How does the machine know where to draw a triangle? Does that depend on what the operator tells it to do?

33 DR. RIEDERS:

Well, it can be that the operator says I want you to count everything that is between a certain space or it can be termed to select that, pick two points that are on a line of where this substance is coming to, because you know, walking past a detector, you don't move past it instantly, nor do all the molecules. At first fewer appear and more and more and more and less and less and less, and so you get this kind of a peak. It is the appearance, the presence and the disappearance that is shown, so you can program how wide a base you want or you can program, draw a line from a point of a certain height. You see on the left the counts are 50, a hundred, up to where the m over Z160. There are these count numbers and so these are height number really in a sense. So it says draw anything that has a height, less than what some of the noise might be, to the next point where you have that same, so you can do it in a variety of ways, but the instrument is instructed over what range to draw the line in the peak.

34 MR. BLASIER:

Now, let me--let me blow up the top of the part of the chart where it says "Mass is 158 to 1--162." What does that tell you?

35 DR. RIEDERS:

That means that the eye of the mass spectrometer--the way that it is counting is that it will count anything that comes past it that has a 158 or a 159 or a 160 or a 161 or a 162 m over Z. If it is a high resolution instrument, then it would stop counting 158.1, 158.2, et cetera, but ordinarily it just counts these unit masses, so that anything in that range is seen by it and this way you can actually get peaks in various places. In some places in some retention times there may be some things that have a moderate amount or more of 159 than in others, 160, but that is all within the mass range in which the daughter ion sits right in the middle.

36 MR. BLASIER:

Now, if you set the machinery to just look at the 160 rather than a range from 158 to 162, are you likely to have a higher peak?

37 DR. RIEDERS:

Yeah, because it can--I told you, it depends--the number that it gets will depend on how rapidly it is checking off. You know, I see one, I see one, I see one. If it is show than it has got two or three that it sees at the same time, then you get a lower number, a lower number of counts. If you focus just on the 160, then that same counts per minute is counting just 160's. Right now it is counting anything between 158 and 162, and so if they are stuck together, it just counts one count rather than separate counts.

38 MR. BLASIER:

Is it the same kind of thing that you might have if I was taking a picture of you with a video camera, if I was scanning it from the Judge over to the bailiff, back and forth like this, you are going to be on the screen less time than if I just put it right on you?

39 DR. RIEDERS:

Right. And so if you needed to sum all those pictures that were taken of me, you would have fewer pictures if it scanned than if you just sat it right on me during that time.

40 MR. BLASIER:

And if you do an even broader scan, the peak would be equivalently less; is that correct?

41 DR. RIEDERS:

Less and less, yes.

42 MR. BLASIER:

And you might not even see it at some point?

43 DR. RIEDERS:

Yes.

44 (Discussion held off the record between Defense counsel.)
45 MR. BLASIER:

This will be 1257-Q.

46 (Deft's 1257-Q for id = slide)
47 MR. BLASIER:

Now, doctor, could you take a look and tell me if the two charts that are on the screen now are the same as the two that I handed to you, 4088 and 4094?

48 DR. RIEDERS:

Yes. They are what appears to be an accurate reproduction of what I have in front of me.

49 MR. BLASIER:

And are those two different tests that the FBI ran on Q206, the sock stain?

50 DR. RIEDERS:

They are two separate tests it looks like on the stain.

51 MR. BLASIER:

Could we go to R.

52 (Deft's 1257-R for id = slide)
53 MR. BLASIER:

Now, doctor, I have highlighted the peaks on those two charts. Does the chart up on the screen there correlate to the peaks that appear on those two chromatograms?

54 DR. RIEDERS:

Yes.

55 MR. BLASIER:

Now, is the retention time on those two charts consistent with the retention time that the FBI determined you would have with EDTA?

56 DR. RIEDERS:

Yes.

57 MR. BLASIER:

And do both of those charts demonstrate not only the presence of the 293 parent ion, but the 160 daughter ion?

58 DR. RIEDERS:

Yes.

59 MR. BLASIER:

Do you have an opinion as to whether, based on those chromatogram from the FBI, whether the presence of EDTA has been demonstrated on the bloodstain from the sock, Q206?

60 DR. RIEDERS:

Just on the basis of the 160 or the entire picture?

61 MR. BLASIER:

The entire picture.

62 DR. RIEDERS:

On the basis of the entire picture, this has been at these concentrations presented as strongly as it can with present technology.

KEY QUOTE
63 MR. BLASIER:

As what?

64 DR. RIEDERS:

As EDTA.

65 MR. BLASIER:

Now, EDTA is what's called an organic compound, correct?

66 DR. RIEDERS:

Yes. It has carbon in it and therefore it is organic.

67 MR. BLASIER:

Anything that has carbon in it is called an organic compound?

68 DR. RIEDERS:

Yes.

69 MR. BLASIER:

And do we know how many there are in the universe, organic compounds?

70 DR. RIEDERS:

No, we don't know how many organic compounds there are in the universe, obviously not, because we are discovering new ones. We are making new ones, but we are also discovering new ones everyday.

71 MR. BLASIER:

Is it possible that there might be some other substance in the universe that gave the same pattern as we see here as EDTA?

72 DR. RIEDERS:

Well, of course. You know, there might be anything in the universe. We don't know all the things that are in the universe, so of course there could be.

73 MR. BLASIER:

Do you know of any specific compound, other than EDTA, that has 293 parent ion, the 160 daughter ion, the appropriate retention time and the other characteristics that you described about solubility, other than EDTA?

74 DR. RIEDERS:

Well, as far as retention time is concerned, I have not seen any chromatography. This is the first time that it was done under these conditions, so I can't relate it. There is no internal standard, so I can't assign a relative amount to it, but as far as the parent ion, the estimated retention time, that means under the conditions that they use a short retention substance, relatively short retention substance, a parent ion of 293 and a daughter ion of 160, I don't know of any such substance and I have not been able to find any in the search of the Merck index of substances. I have looked and I haven't found any.

75 MR. BLASIER:

Could I have another document marked, let's make it c of that last series because it goes together, which would be 1259-C?

76 THE COURT:

All right.

77 (Deft's 1259-C for id = slide)
78 MR. BLASIER:

Doctor, take a look at this first and then we will put it on the elmo. Does this appear to be what is called a full daughter ion scan chromatogram for Q206?

79 DR. RIEDERS:

Yes. It scans all the masses from 130, which I think is one of the lowest daughter ions of the 293 ion, all the way up to 295, which is just--which is the molecular ion plus three.

80 MR. BLASIER:

Now, I take it what this is, it is looking for the other pieces in addition to the 160?

81 DR. RIEDERS:

That is correct.

82 MR. BLASIER:

Can we put this up on the elmo, please.

83 (Discussion held off the record between Defense counsel.)
84 MR. BLASIER:

Doctor, could you look up at the top right-hand corner and tell us what range was being scanned with that chromatogram?

85 DR. RIEDERS:

From mass 130, which is one of the break-up pieces of the parent ion, when that breaks up, it gives rise to 130 among others, all the way up to 295, which, as I said, is a piece larger than the molecule.

86 MR. BLASIER:

Now, using my analogy of a television camera, is that--are we talking about a very long range of scan?

87 DR. RIEDERS:

Yes.

88 MR. BLASIER:

So is it fair to say that any particular point that is being looked at is not being looked at very frequently because of the broad range of the scan?

89 DR. RIEDERS:

Yes.

90 MR. BLASIER:

Now, in this particular one there are no peaks or triangles identified, correct?

91 DR. RIEDERS:

Well, they are not identified by being drawn as triangles or numbered; that's correct.

92 MR. BLASIER:

Do you see any things on there that could be potential indications of the presence of these ions at around the right retention time?

93 MS. CLARK:

Well, objection, your Honor, under 352, as previously stated.

94 THE COURT:

Overruled.

95 MS. CLARK:

Can we approach, your Honor?

96 THE COURT:

Overruled.

97 DR. RIEDERS:

Yes, indeed. We have, within the same range within which we determined before, a countable picture, because it was more focused, remember than in the previous one. We do have the highest peaks in that chromatogram fall into the same retention time range for all of the ions as they did for the ones that were clearly recognized as being 160 ions because of the focus on them.

98 MR. BLASIER:

Now, I'm pointing my pen to the top one, which is the 132 daughter ion. Is that what you are talking about as the peak right in here, (Indicating)? Right in there, (Indicating)?

99 DR. RIEDERS:

Yes, except that the way that this--in the electrospray you get movement; you don't get that clear a definition. There are several points in here which you would find with 160 daughter ions.

100 MR. BLASIER:

And now the 160 chart right below that, is that what you are talking about there, that peak is a possible indication of the presence of that?

101 DR. RIEDERS:

Right, yes.

102 MR. BLASIER:

Now, you will acknowledge, will you not, that these peaks aren't nearly as well-defined as the ones we have looked at before; is that correct?

103 DR. RIEDERS:

Yes, of course they are much smaller. The area is smaller and the peak is smaller because all of the energy for counting is spread over the range of 130 to--

104 MR. BLASIER:

295?

105 DR. RIEDERS:

--to 295, whereas in the other one it is concentrated. All the energy of counting is to individually count each 160 fragment along with the other ones next--close next to it.

106 MR. BLASIER:

Does this mean that the EDTA that you saw in the earlier two charts has somehow disappeared?

107 DR. RIEDERS:

No. You have a less sensitive method, so the same amount of EDTA will show up as a peak that is not as tall and that doesn't have as much of an area. It looks fuzzier. It is looking at it through a somewhat darker glass than you looked at the 160, but you get more information in this run.

108 MR. BLASIER:

I have two other charts.

109 (Discussion held off the record between Deputy District Attorney and Defense counsel.)
110 MR. BLASIER:

Could we have these marked as next in order, a and b?

111 THE COURT:

Is this 160--1260.

112 (Deft's 1260-A & b for id = slides)
113 MR. BLASIER:

1260-A and b?

114 THE COURT:

Yes.

115 MR. BLASIER:

Your Honor, for the record, 1260-A has D.A. discovery no. 4084 and is a chromatogram from a testing from Q204, the stain from the back gate, and 1260-B is D.A. discovery no. 4049, is a second test on the same stain from a different day.

116 MR. BLASIER:

Dr. Rieders, let me show you 1260-A and 1260-B. Does this appear to be two chromatograms from two different tests on two different days of the stain from the back gate at Nicole Brown Simpson's condominium?

117 DR. RIEDERS:

Well, I can't see the dates. They are different times, but the date is not apparent.

118 MR. BLASIER:

Now--

119 DR. RIEDERS:

That is what you have on the side, 2/22 and 2/28.

120 MR. BLASIER:

Yes.

121 DR. RIEDERS:

Is that the date?

122 MR. BLASIER:

Yes.

123 DR. RIEDERS:

Yes.

124 MR. BLASIER:

Incidentally, when you were provided with the materials from the FBI the first time, were you able to tell what dates the tests were done on them?

125 DR. RIEDERS:

On these papers?

126 MR. BLASIER:

Yes.

127 DR. RIEDERS:

No.

128 MR. BLASIER:

And why was that?

129 DR. RIEDERS:

They weren't shown. They were cut off or they weren't shown.

130 MR. BLASIER:

Were they in the order in which the tests had been run?

131 DR. RIEDERS:

No.

132 MR. BLASIER:

Were they somewhat mixed up?

133 DR. RIEDERS:

Yes.

134 MR. BLASIER:

Could we have 1257-Q. I'm sorry.

135 (Discussion held off the record between Defense counsel.)
136 MR. BLASIER:

Let me show you what is 1257-S.

137 (Deft's 1257-S for id = slide)
138 MR. BLASIER:

Does this appear to be an accurate depiction of both the chromatograms, 4049, 4084, two tests on the back gate stain on two different days?

139 DR. RIEDERS:

Yes.

140 MR. BLASIER:

Next slide, please.

141 MR. BLASIER:

Doctor, do the peaks shown on those two chromatograms have a retention time consistent with the presence of EDTA?

142 DR. RIEDERS:

Yes, they do. They have the same retention time range. They have a retention time well within the range shown by EDTA.

143 MR. BLASIER:

And do they also demonstrate the presence of both the 293 parent ion and the 160 daughter ion?

144 DR. RIEDERS:

Yes, because without the 293 you can't get the 160 in the ms/ms mode.

145 MR. BLASIER:

Do you have an opinion on whether, based on those chromatograms, there is EDTA present in the stain from the back gate?

146 DR. RIEDERS:

In my opinion, yes, it demonstrates that there is EDTA present in that stain.

KEY QUOTE
147 MR. BLASIER:

Now, what are negative controls?

148 DR. RIEDERS:

Negative controls are samples put through the same procedure as your sample at issue and samples which are known not to contain any added substance that you are looking for. And if run in the appropriate sensitivity they are negative controls because by the method used they will give a negative test result if the--if, a, there is in fact no more or if there isn't any there, and b, that the method that has been applied has worked as well there.

149 MR. BLASIER:

Did Agent Martz of the FBI test an area of the sock that did not have any apparent blood on it?

150 DR. RIEDERS:

Yes. That is what he states he did.

151 MR. BLASIER:

Is that what is meant by negative control?

152 DR. RIEDERS:

I believe so. That is what he meant, yes.

153 MR. BLASIER:

And did that indicate the presence of EDTA?

154 DR. RIEDERS:

No, it did not.

155 MR. BLASIER:

And what does that tell you about the bloodstain?

156 DR. RIEDERS:

Well, that means since it is my opinion that the bloodstain contained EDTA, that that came from the blood and not from the sock.

157 MR. BLASIER:

Does that rule out any contribution from laundry detergent or something else that might be throughout the entire sock?

158 DR. RIEDERS:

Reasonably certainly, yes, unless of course the blood was dotted with laundry detergent, you know, and nothing else on the sock was.

159 MR. BLASIER:

Now, as to the back gate, did Agent Martz run any negative control on the back gate?

160 DR. RIEDERS:

Yes.

161 MR. BLASIER:

And were those from a swatch taken from an area just away from the blood but had no blood on it?

162 DR. RIEDERS:

Yes.

163 MR. BLASIER:

And how many of those negative controls did he run?

164 DR. RIEDERS:

I recall four.

165 MR. BLASIER:

What were the results of his testing on those four?

166 DR. RIEDERS:

Three were negative and one was positive.

167 MR. BLASIER:

When you get a mixture like that, what is the interpretation?

168 DR. RIEDERS:

Well, the interpretation is that you better run four more or do something like that, because you have something there which doesn't make sense.

169 MR. BLASIER:

But the fact that you have three negative controls coming back negative, what does that indicate?

170 DR. RIEDERS:

Well, you know, if you want to put it on a majority basis that there is a 75 percent probability that it is truly negative and that the fourth one is something that happened, either contamination, you know, an accident, or you know, something happened to that sample or that it got mixed up. I can't tell you what, obviously, but--

171 MR. BLASIER:

Does the fact that three of the negative controls are negative indicate that there was no EDTA on the control swatch taken from the gate but not from the blood?

172 DR. RIEDERS:

Oh, yes, it does.

173 MR. BLASIER:

Now, were you asked to consider the question of whether the FBI's methods were capable of reliably determining the amount of EDTA that the test detected to any degree of analytical certainty or accuracy?

174 DR. RIEDERS:

The amount, no, I really don't think that it is capable of doing a reasonably acceptable quantitative analysis job at all, which is inherent not in what the FBI did, but in the electrospray method.

175 MR. BLASIER:

Were you asked to determine whether the FBI methods were capable of reliably determining concentrations of EDTA in the evidence sample?

176 DR. RIEDERS:

No way, and not only because of what I said before, but in order to do concentrations you would really have to know how much sample was in that swatch that you analyzed, how much got wiped off there, how much blood was in there that you have, and there is no way that you can really tell that from the tests that were done.

177 MR. BLASIER:

Now, again by concentrations we are talking about parts per million?

178 DR. RIEDERS:

Or paths per billion or whatever, yeah.

179 MR. BLASIER:

Was the FBI's testing methodology capable of determining parts per billion, in your opinion?

180 DR. RIEDERS:

Well, it--no, it was not, not at all.

181 MR. BLASIER:

Now, with the technique that the FBI used we had talked previously about ion count, in other words, how high the peak is. Do you recall that?

182 DR. RIEDERS:

Yes.

183 MR. BLASIER:

With this testing methodology, when they don't use an internal standard, can you relate one peak height to the peak height of a test done on a different day?

184 DR. RIEDERS:

Only saying that this is much bigger than that, but which is right, which is wrong or where is right or wrong, you can't say.

185 MR. BLASIER:

Well, does the peak height vary depending on the day that you do the test, or can it?

186 DR. RIEDERS:

Well, even with the same day you have as much as a seven-fold variation between two runs each on a 50 parts per million known sample.

KEY QUOTE
187 MR. BLASIER:

And did you examine--did Agent Martz run several known EDTA stands, 50 parts per million, to see what kind of peak heights he got?

188 DR. RIEDERS:

Yes, of course.

189 MR. BLASIER:

And was there a lot of variation in those peak heights?

190 DR. RIEDERS:

Yes, seven-fold.

191 MR. BLASIER:

Does that indicate to you as to whether you can use peak height to accurately determine concentration?

192 DR. RIEDERS:

Not individual peak height, no.

193 MR. BLASIER:

Now, let's say if you wanted to use this method as a way of quantifying how much EDTA you found, what would be the appropriate procedure?

194 DR. RIEDERS:

You could do it if you used an internal standard that I had mentioned before where the ratio of the area or of the peak heights is constant at a given concentration, and where the two behave in a very, very similar manner.

195 MR. BLASIER:

Now, with the--an internal standard, is that a substance that is very close to the EDTA, but enough difference so that you can tell the difference?

196 DR. RIEDERS:

That is the ideal, that you can tell the difference, but that otherwise the behavior is not significantly different. The properties are sufficiently different so you can separate them either with the liquid chromatograph or with a mass spectrometer.

197 MR. BLASIER:

And are those kind of compounds available commercially?

198 DR. RIEDERS:

Yes, sure.

199 MR. BLASIER:

Now, when you would use an internal standard, do you actually put the internal standard with the evidence that you are testing or do you do it in a different run?

200 DR. RIEDERS:

No, no, you do it right in the sample. The ideal thing is to--if you have a swatch like he had--is to put the internal standard on the swatch, known amount, and then extract it, really put it on the swatch, let it dry, let it age a while because you didn't just prepare it. You know, it has been around a while, and then extract it. You know how much you should find from that. Now, of course you run also control where you just put neatly the internal standard into the machine and see the amount that I'm going to put on the swatch would show up. If I get a hundred percent of it back at certain height and certain area and then I put it on the swatch, then I put it in the water and so that eventually you end up with a chromatogram like this with two peaks close to each other but far enough apart so that you can tell one from the other.

201 MR. BLASIER:

And does that allow you, since you know how much of the internal standard you put in there, does that allow you to then quantify how much was in the evidence?

202 DR. RIEDERS:

Yes, but taking the ratio of, let's say, the height of the known over the height of the unknown or visa versa and comparing that with the standard, because that ratio is going to be reasonably constant.

203 MR. BLASIER:

Did Agent Martz use an internal standard in his testing?

204 DR. RIEDERS:

No.

205 MR. BLASIER:

Is using an internal standard very common practice when running mass spec tests?

206 DR. RIEDERS:

It is a standard procedure wherever one is available, not only for quantization, but also for retention time characterization. If one moves to a different retention time, so does the other, so again, that relative retention time is kept much tighter that way. And it is almost--it has almost become a requirement of chromatography, in quotes of course.

207 MR. BLASIER:

Now, let's assume hypothetically that the stain from the back gate was put there using blood from a reference tube that had EDTA in it and let's assume also hypothetically that the stain in the sock was placed there using blood with EDTA in it. Were you asked to consider the question of how much EDTA you would expect to find if you then tested those bloodstains eight months later?

208 DR. RIEDERS:

Yes, I was asked.

209 MR. BLASIER:

Now, is it important, when you are running a sample, if you want to determine how much of something like EDTA is present, that you know how much you start with?

210 DR. RIEDERS:

How much sample you start with?

211 MR. BLASIER:

Yes.

212 DR. RIEDERS:

Yes, of course.

213 MR. BLASIER:

Now, if you had a blood swatch, let's say, from the back gate or a piece of the sock from the sock that appeared to have blood in it, can you tell how much blood is there by just looking at it?

214 DR. RIEDERS:

I can't.

215 MR. BLASIER:

What are the standard procedures used to determine the quantity of blood that might be in a swatch?

216 DR. RIEDERS:

Well, you bring it into a water solution, preferably with a little ammonia, because old stains are hard to get out, and you read that in a spectrophotometer for the hemoglobin content or for the hematin content, which is a fairly selective method, or else for the soret band absorbing proteins as you call them.

That is one way. It is a simple way because you don't do anything to the sample. You can handle it afterward, do anything you want to with it. You just put it in a light spectrophotometer and you get the spectrum and at certain wavelength standards you determine how much hemoglobin, which is really what the blood has most of, or if you are dealing with serum or plasma, how much protein based on the soret band which is also an absorption in the ultraviolet region there is.

217 MR. BLASIER:

Are there any other?

218 DR. RIEDERS:

There are other ways of doing it. I mean, you know more about this probably than I do, because you have been so well-educated in this. You can determine the amount of DNA in it and that tells you how much blood there was, because blood has a fairly known amount of DNA in it. You can also determine other substances in there that are characteristic of blood. For instance, if your background material doesn't have any iron in it, the measurement of iron in a sample like this is a good measure of hemoglobin because most of the iron in blood come from hemoglobin. Again, assuming that this is blood, not serum or plasma. What I usually do is spectrophotometry and/or iron determination and/or copper and zinc, if the--you know, if I have a sample that is diluted blood and I want to know how dilute it is or how much there is, so you can do it, you know.

219 MR. BLASIER:

Is that equipment that you would expect to find in any well-equipped lab?

220 DR. RIEDERS:

I'm sure that is available.

221 MR. BLASIER:

Do you know whether the FBI has that kind of equipment?

222 DR. RIEDERS:

Well, I don't know what their lab has, but if they have got an incident, I'm sure they couldn't do without the others.

223 MR. BLASIER:

Did you see anything in agent Matheson's work papers indicating that he used any method other than just looking at a stain to determine how much blood he started with from the evidence?

224 DR. RIEDERS:

Well, I only saw in his papers here on--he made stain sizes on a--on a cloth and said when I put a drop on I get so much stain and when I put--you know, on another one, I get such an area and the area that I have is--comprises of a fraction of that, which I don't think is a workable way of doing it, unless you do it to exactly the same material, do it many, many times, do averages, standard deviations and other things, so--because what he had wasn't a drop of blood placed on the kind of material he was testing or on anything, for that matter, but in the case of the gate it is something that got wiped off again.

225 MR. BLASIER:

Now, did you evaluate or look at the method that he used to attempt to extract the blood that was in the evidence, the sock stain and the back gate swatch to extract the blood from that?

226 DR. RIEDERS:

Yes. I looked at it.

227 MR. BLASIER:

And what was that method, briefly?

228 DR. RIEDERS:

Essentially he took a--he took what he had, you know, what was available, a portion of it, and he put it into 25 microliters of water.

229 MS. CLARK:

Objection, your Honor. This is all hearsay. This witness wasn't present.

230 THE COURT:

Sustained.

231 MR. BLASIER:

Now, let me ask you--

232 THE COURT:

The answer is stricken. The jury is to disregard the answer.

233 MR. BLASIER:

Let me ask you, hypothetically, if you took, let's say, first of all, an old stain that had been on a swatch for eight months and put it in water, plain water, let's say 25 microliters, and let it soak for 45 minutes and centrifuged it, is that an efficient way to remove all of the blood from the stain?

234 MS. CLARK:

Objection, improper hypothetical, no facts this evidence, no foundation, your Honor.

235 THE COURT:

Overruled. Overruled.

236 DR. RIEDERS:

It is a way but you won't get a hundred percent, you will get a relatively low recovery from an old stain. You know, a dried stain where it is dried for all that period of time, is bone dry, it won't all dissolve in the water, much less than all, just a small portion or just a small--

237 MR. BLASIER:

What would be an acceptable technique to remove all of the blood from the evidence item?

238 DR. RIEDERS:

It is--to remove all the blood really what you would have to do is if you could only use water, you could only use water, is to repeat that. You put it in 25 microliters, you let it sit for an hour, you shake it for an hour, you centrifuge it, you take it out, put it in another 25 microliters and every time you run some kind of a non-destructive test to see are you still getting blood out, are you still getting blood out, until you don't see any more coming out, then you are pretty sure you have gotten it all out. You can even change that by using, for instance, dilute ammonia, which is a better solvent for dried blood than plain water, but it, too, you have to establish that this will all come out by doing sequential extractions and mesh in each one the amount of the sample--blood that is in it in one way or another.

239 MR. BLASIER:

Would you agree that if you were testing an old bloodstain to determine how much EDTA was present and you did not extract all of the blood from the stain, you are going to find a smaller amount of EDTA than might actually be there?

240 MS. CLARK:

Objection, that calls for speculation.

241 THE COURT:

Sustained.

242 MR. BLASIER:

If you don't--

243 THE COURT:

Rephrase the question.

244 MR. BLASIER:

If you don't remove all of the blood from the evidence swatch are you going to--and the blood has EDTA in it, are you going to find less EDTA than is in the whole stain?

245 MS. CLARK:

Objection, improper hypothetical and also calls for speculation.

246 THE COURT:

Overruled.

247 DR. RIEDERS:

Of course. I mean that is very self-evident. If you don't get it all, you have less than if you get it all, whatever it is.

248 MR. BLASIER:

Now, incidentally, are you aware of any other case or any published literature on the issue of determining levels of EDTA in bloodstains in forensic cases?

249 DR. RIEDERS:

No, I am not. I don't think there is anything published. I have asked around. I don't know of anyone who has done it.

250 MR. BLASIER:

Would you say that this is brand new ground in terms of that particular test I told you about?

251 DR. RIEDERS:

Yes, sure. For EDTA in a blood swatch of this type, it is--it is brand new ground. EDTA has been determined in blood, but not in a blood swatch in a forensic case, et cetera, et cetera, to any published extent or anyway I know.

KEY QUOTE
252 MR. BLASIER:

Now, the chromatography and the mass spec techniques, those are all techniques that have been around for a long time, haven't they?

253 DR. RIEDERS:

Yes. Well, they have--the mass spectrometry and chromatography is fairly old.

254 MR. BLASIER:

Did you see anything in the paperwork that you reviewed indicating that the FBI did any studies to determine the differences between extracting blood from an old stain versus a new stain?

255 DR. RIEDERS:

No, I did not.

256 MR. BLASIER:

By the way, if you have a swatch that is made from a bloodstain, for instance, on a back gate, can you tell from looking at that swatch how much blood is in it?

257 DR. RIEDERS:

I can't, no.

258 MR. BLASIER:

Can that vary from one swatch to the next?

259 DR. RIEDERS:

I'm sure it will, greatly.

260 MS. CLARK:

Objection, that calls for speculation as well.

261 THE COURT:

Overruled.

262 MR. BLASIER:

Now, in the context of the testing done by the FBI, what is a positive control?

263 DR. RIEDERS:

A positive control in that context, as in other contexts, is one in which the substance at issue has been added in a known quantity and preferably not only in a known quantity but to a known concentration. That means a situation where you know how much sample you have and how much you are adding. That is concentration. If you don't know how much sample you have and you put it on a microgram, then you know you've put one microgram in, but you don't know what the concentration is because you don't know one microgram per what.

264 MR. BLASIER:

Hypothetically, if you had a bloodstain on a metal gate that was not collected, in other words, was out in the outside environment subject to the weather and other environmental factors for a period of from a day to two or three weeks, what effect would those conditions have on the presence of EDTA in the blood?

265 DR. RIEDERS:

Now--

266 MR. BLASIER:

Assuming that the original stain had--

267 DR. RIEDERS:

You put a wet stain on and let it sit there dry and be exposed for a day or more?

268 MR. BLASIER:

With EDTA blood, yes.

269 DR. RIEDERS:

With EDTA blood? There would be some degradation from environment factors. How much should really be determined experimentally, but I'm reasonably sure there would be because it has been done.

270 MS. CLARK:

Objection. No foundation, lack of expertise.

271 THE COURT:

Sustained. The answer is stricken.

272 MR. BLASIER:

Have you reviewed literature on a study that is called the photodegradation of EDTA?

273 DR. RIEDERS:

Yes.

274 MR. BLASIER:

And what did that article tell you?

275 DR. RIEDERS:

Well, basically that article tells us that if you have EDTA solution, in this case the EDTA in the German river called the Neckar, N-E-C-K-A-R. And if you sample that with EDTA in it on a sunny day in Germany, that the amount of EDTA that is in that solution is going to break down half--half of it is going to break down in less than ten minutes from the sunshine itself. So that is photodegradation. It is because of the energy of the sun rays interacting with the EDTA in the water. The material that was used for that was iron EDTA--was an iron chelate of EDTA. Degradation of EDTA is described for sludge, it is described in the literature for bacterial degradation, so-called biotic, by living organism, and a biotic, by the presence of oxygen and absence of oxygen, so it is known it degrades. If you take a sample of EDTA in blood and freeze it, it will stay there.

276 MS. CLARK:

Objection, your Honor. This is outside of scope of expertise.

277 THE COURT:

Sustained.

278 MS. CLARK:

Also, the article is irrelevant.

279 THE COURT:

Proceed.

280 MR. BLASIER:

If you were trying to determine how much EDTA you would have in an EDTA bloodstain that had been subjected to one day to two or three weeks outside environment on a particular type of metal fence, how would you determine that?

281 DR. RIEDERS:

Well, I have done things like this, and in this case it is obvious, you get a material which is as alike as possible to the metal fence, maybe a piece of the metal fence, and you put ten dots of EDTA blood on it and you put on it ten drops--ten dots of blood in other places, of blood that doesn't have any EDTA in it, that is not in an EDTA tube, but it is normal human blood. Normally it contains virtually no EDTA. Then what you do is you analyze the control or more than one control. That means you take a little bit of an area where there is no blood and you take that and try to know how much you have and analyze it. Then you wash off one of the spots that has EDTA and another spot that doesn't have EDTA, you analyze all three and you repeat that everyday for a week or something like that, for a portion of the time. If it just for a few hours that you are interested in, then you repeat it during a period of several hours. You analyze it and you see whether it is broken down, you know, whether the one that was put there an hour ago has less in it than the one that you took off right away and analyzed or the one that you took--was there for a week. And if during that whole period there is no breakdown, then you say, well, I don't know whether it would break down in eight months like you are--or eight weeks or whatever, but at least I know that during that period it is stable. Usually in a substance, my experience is, that a substance that does break down, within a week you will be able to tell that it does. Then carefully can extrapolate say that in eight months there is going to be nothing there or I think there may be some there, but that becomes somewhat speculative.

282 MR. BLASIER:

Now, is that what you have described as a possible method to determine that, is that part of what should be a validation study on the method?

283 DR. RIEDERS:

Well, that is what I would call a validation of the method for this purpose.

284 MR. BLASIER:

Did you see anything in the paperwork from the FBI indicating that they did any test at all to determine how much EDTA would have been lost under the conditions that we described?

285 DR. RIEDERS:

No, I did not.

286 MR. BLASIER:

Now, let me ask you about the sock. Let's assume hypothetically that EDTA blood was put on the sock at some point in time and let's assume further than between the time that blood was put on there and the time it was analyzed by the FBI it was examined several times using high intensity lights involving physical manipulation in the process of examining it. Can you tell us whether or not that would result in the degradation of the EDTA that was originally in that blood?

287 MS. CLARK:

Objection, improper hypothetical, assumes a fact that has not been proven.

288 THE COURT:

Anything else?

289 MS. CLARK:

And calls for--I'm sorry. Calls for speculation, outside the expertise.

290 THE COURT:

Sustained.

291 MR. BLASIER:

Doctor, photodegradation, does that work when you shine a light on something?

292 DR. RIEDERS:

That is what photodegradation is, from light energy.

293 MR. BLASIER:

And the one study that you have cited looked at photodegradation and found that it can occur with EDTA, correct?

294 MS. CLARK:

Objection, that article is irrelevant.

295 THE COURT:

What form of EDTA was used--is used in the purple vials?

296 MR. BLASIER:

Well, actually it is--do you want me to answer?

297 THE COURT:

Yes, I would like to know.

298 MR. BLASIER:

It can be there in several forms; iron EDTA, calcium EDTA, several others.

299 THE COURT:

What was used here?

300 MR. BLASIER:

I don't know. I mean it can--it picks up iron is what it does.

301 THE COURT:

I understand that, but the one article you have talks about the water quality in the Neckar Valley River.

302 MR. BLASIER:

Uh-huh.

303 THE COURT:

A delightful place. That is why the Germans call it the romantic highway, but it doesn't tell me a lot about this case.

KEY QUOTE
304 MR. BLASIER:

Let me ask a different question.

305 THE COURT:

Approach the side bar with the court reporter, please.

Temperature

procedural

Key Quotes (5)

Dr. Fredric Rieders
On the basis of the entire picture, this has been at these concentrations presented as strongly as it can with present technology. As EDTA.
Core defense opinion: the FBI's own chromatograms prove EDTA is present in the sock bloodstain, supporting the theory that blood from a preserved reference tube was planted.
Dr. Fredric Rieders
In my opinion, yes, it demonstrates that there is EDTA present in that stain.
Explicit opinion on the back gate stain (Q204), extending the EDTA-present finding to the second key piece of blood evidence.
Dr. Fredric Rieders
For EDTA in a blood swatch of this type, it is — it is brand new ground. EDTA has been determined in blood, but not in a blood swatch in a forensic case, et cetera, et cetera, to any published extent or anyway I know.
Cuts both ways — legitimizes novelty of defense theory while also undercutting the FBI's methodology as untested against published standards.
Lance A. Ito
A delightful place. That is why the Germans call it the romantic highway, but it doesn't tell me a lot about this case.
Ito skeptically dismisses the relevance of the photodegradation study on EDTA in a German river, foreshadowing the sustained objections and sidebar that end the session.
Dr. Fredric Rieders
Well, even with the same day you have as much as a seven-fold variation between two runs each on a 50 parts per million known sample.
Directly undermines the FBI's ability to quantify EDTA levels — a seven-fold variation in known standards makes any concentration claim scientifically untenable.

Evidence (9)

Defense 1259-A
FBI chromatogram of sock stain Q206 (DA discovery 4088), showing 160 daughter ion and 293 parent ion
introduced and analyzed
Defense 1259-B
Second FBI chromatogram of sock stain Q206 (DA discovery 4094), different test run
introduced and analyzed
Defense 1257-Q
Composite slide of both Q206 sock stain chromatograms displayed together
introduced for comparison
Defense 1257-R
Same composite with peaks highlighted
introduced to aid jury visualization
Defense 1259-C
Full daughter ion scan chromatogram of Q206 (broader mass range 130–295), less focused than prior runs
introduced and discussed to show EDTA signal across multiple ions
Defense 1260-A
FBI chromatogram of back gate stain Q204 (DA discovery 4084), test dated 2/22
introduced and analyzed
+ 3 more

Notable Exchanges (3)

Robert BlasierLance A. ItoMarcia Clark
After Rieders cited a German river study to support EDTA photodegradation, Ito questioned its relevance to the case — pointing out the article concerns water quality in the Neckar River, not forensic bloodstains — and sardonically called it 'a delightful place' before ordering a sidebar. Clark had sustained objections on this line throughout.
skeptical / gently dismissive
Robert BlasierMarcia ClarkLance A. Ito
Clark objected when Rieders began describing Agent Martz's extraction procedure, arguing hearsay since Rieders wasn't present. Ito sustained, struck the answer, and instructed the jury to disregard. Blasier pivoted to a hypothetical to get the same information in.
strategic
Robert BlasierDr. Fredric Rieders
Extended analogy comparing mass spectrometer scanning to a video camera panning across a room — Rieders enthusiastically adopted the metaphor to explain why a broader scan produces shorter, fuzzier peaks, making the science accessible to the jury.
pedagogical

Light Moments (2)

Lance A. Ito
After the German river EDTA study came up, Ito deadpanned: 'A delightful place. That is why the Germans call it the romantic highway, but it doesn't tell me a lot about this case.'
Dr. Fredric Rieders
Rieders, in the middle of a long answer about hemoglobin measurement methods, turned to Blasier and said 'You know more about this probably than I do, because you have been so well-educated in this,' lightly complimenting the attorney's mastery of the technical material.

Credibility Attacks (1)

⚔ Agent Martz (FBI)
methodological critique
Rieders systematically attacked Martz's EDTA testing: (1) no internal standard used, creating up to seven-fold variation in results; (2) inadequate extraction — soaking an old stain in 25 microliters of plain water for 45 minutes recovers only a fraction of the blood; (3) no validation study comparing old versus new stain extraction efficiency; (4) no photodegradation study to account for EDTA loss during months outdoors; (5) FBI provided chromatograms to Rieders with dates cut off and in scrambled order.

Objections

12 objections (5 sustained, 6 overruled)
Proceeding 6995 • 305 utterances • Defense witness
Criminal Trial
Department 103
⚖️ Start
📂 JUL 24, 1995 📄 Direct examination of Dr. Fred
JUL 24, 1995 KRT DvH TD